Master class:
Сhallenges in liquid chromatography Orthogonal chromatographic methods
in innovative drug development

Early Registration Discount
Early registration until March 15, 2020
1,665 NIS+VAT
Registration from March 16, 2020
1,850 NIS + VAT
Lecturer: Dr. Vladimir Ioffe

Date: 24 March 2020
Location: Kfar Maccabiah, Ramat Gan
General Information
Duration: 1 - Day Course
Hours: 09:00 – 17:00
Price: 1,850 NIS + VAT
Credit Points: 1
SKU: 20920
Course Language: Hebrew
About the Course
This seminar is based on real cases of analytical development to support chemical and pharmaceutical R&D's dealing with innovative projects.

Presenting chromatographic development for comparatively simple molecules facilitates understanding and makes the seminar suitable for students and industrial analysts with limited experience.
One of the most important points in analytical development for pharmaceutical industry to be taken into account in an industrial R&D – to develop reliable and robust methods, friendly to a terminal user and – as simple as possible, since they are intended to be routinely run by QC analytical laboratories at a production site (“QC-able procedures”).
Who should attend
This knowledge sharing seminar (Master Classes) is intended for the analytical chemists having experience in HPLC or related techniques, working in Quality Control or Research and Development laboratories, as well as for university students and post-graduates in the field of modern instrumental methods of analysis.
Master class:
Сhallenges in liquid chromatography Orthogonal chromatographic methods
in innovative drug development
Benefits to the Participants
The aim of this seminar is to elaborate a mindset of a developer of liquid chromatography methods and to converse the need in complementary “orthogonal” chromatographic procedures and diverse detection techniques for a complex coverage of all the characteristics of a pharmaceutical material
Contact us
  • Full Name
  • Email
  • Phone
  • Notes
  • Send
Issues to be covered
The first molecule has a cis-double bond, a chiral center in α-position to aromatic ring and a labile ester bond. The product and starting materials for its synthesis (which are also its dominant degradation products) have extremely different polarity and lipophilicity. The peak of one of them, which is very polar, elutes before the solvent front. The other cannot be seen using UV detector due to lack of chromophore. This caused a need in developing complementary methods: the method for “Polar Impurities” developed using a mixed-mode HPLC column and the method for lipophilic "UV-invisible" – using non-silica based RP column and evaporative detector (ELSD or Corona CAD). In addition, enantioselective separation under normal phase chromatographic conditions has been developed.

Principles of work of evaporative detectors are explained and the benefits of using alternative (non-UV) detection techniques discussed. Data processing for non-linear detection in HPLC is explained. Specific case of MS detection following normal phase liquid chromatography is also addressed.

The second molecule is strongly lipophilic and poorly soluble in water. RP HPLC method for lipophilic API requires a high content of organic solvent both in eluent and diluent.

Due to very low water solubility of API, a lipid-based formulation has been prepared, which demanded to either develop a complex extraction procedure to be used with RP method, or chose an alternative analytical technique – normal phase (NP) HPLC; where the entire drug product may be dissolved in eluent-compatible organic solvent.

Principles of HPLC method development, both for RP and NP chromatography, are discussed in terms of various retention mechanisms and their combinations in chromatographic separations. Special attention is given to available tools in development of NP HPLC methods.

Since NP HPLC provides fewer possibilities in mobile phase composition for optimization of separation, a “scouting of columns” attitude had to be applied. Usefulness of less volatile solvents in NP HPLC is explained.
Real cases of unpredictable troubleshooting sessions illustrate the material. Influence of HPLC hardware and its compatibility with HPLC methods is also pointed out.

Questions of compliance of analytical methods for pharmaceutical industry to ICH (FDA, etc.) guidances are briefly reviewed.
About The Lecturer
More Courses from this Category
More Courses From Lecturer
Learning from us